$23.23
At close: Apr 16, 11:11 AM EDT
Comments
Loading...
Kissei Pharmaceutical Analyst Ratings and Price Targets | OTC:KSPHF | Benzinga
Kissei Pharmaceutical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kissei Pharmaceutical Corp from these most-recent analyst ratings.
Analyst Ratings for Kissei Pharmaceutical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Kissei Pharmaceutical (KSPHF) stock?
There is no price target for Kissei Pharmaceutical
What is the most recent analyst rating for Kissei Pharmaceutical (KSPHF)?
There is no analyst for Kissei Pharmaceutical
When was the last upgrade for Kissei Pharmaceutical (KSPHF)?
There is no last upgrade for Kissei Pharmaceutical
When was the last downgrade for Kissei Pharmaceutical (KSPHF)?
There is no last downgrade for Kissei Pharmaceutical.
When is the next analyst rating going to be posted or updated for Kissei Pharmaceutical (KSPHF)?
There is no next analyst rating for Kissei Pharmaceutical.
Is the Analyst Rating Kissei Pharmaceutical (KSPHF) correct?
There is no next analyst rating for Kissei Pharmaceutical.
Browse analyst ratings and price targets on all stocks.
